Exploring the Significance of TP53, ABCB1 and GST Polymorphisms on Susceptibility and Pharmacogenetics in Argentinian Patients with Chronic Myeloid Leukemia

被引:0
|
作者
Weich, Natalia [1 ]
Ferri, Cristian [1 ]
Beatriz Moiraghi, Elena [2 ]
Nelida Bengio, Raquel Maria [3 ]
Amanda Giere, Isabel [4 ]
Pavlovsky, Carolina [4 ]
Larripa, Irene [5 ]
Freya Fundia, Ariela [1 ]
机构
[1] CONICET Acad Nacl Med, IMEX, Lab Hematol Genet, Buenos Aires, DF, Argentina
[2] HOSP RAMOS MEJIA, Buenos Aires, DF, Argentina
[3] IIHEMA Acad Nacl Med, Buenos Aires, DF, Argentina
[4] FUNDALEU, Buenos Aires, DF, Argentina
[5] Conicet Acad Nacl Med, IMEX, Lab Hematol Genet, Caba, Argentina
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Influence of CYP1A1, GST polymorphisms and susceptibility risk of chronic myeloid leukemia in Syrian population
    Walid Al-Achkar
    Ghassan Azeiz
    Faten Moassass
    Abdulsamad Wafa
    Medical Oncology, 2014, 31
  • [22] Influence of CYP1A1, GST polymorphisms and susceptibility risk of chronic myeloid leukemia in Syrian population
    Al-Achkar, Walid
    Azeiz, Ghassan
    Moassass, Faten
    Wafa, Abdulsamad
    MEDICAL ONCOLOGY, 2014, 31 (05)
  • [23] Codon 72 polymorphisms in the tumor suppressor gene TP53 in patients with chronic myelogenous leukemia.
    Bergamaschi, G
    Merante, S
    Galli, A
    Orlandi, E
    Lazzarino, M
    Cazzola, M
    BLOOD, 2003, 102 (11) : 419A - 420A
  • [24] Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia
    Stephany Corrêa
    Renata Binato
    Bárbara Du Rocher
    Morgana TL Castelo-Branco
    Luciana Pizzatti
    Eliana Abdelhay
    BMC Cancer, 12
  • [25] Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia
    Correa, Stephany
    Binato, Renata
    Du Rocher, Barbara
    Castelo-Branco, Morgana T. L.
    Pizzatti, Luciana
    Abdelhay, Eliana
    BMC CANCER, 2012, 12
  • [26] TP53 Pro72 allele potentially increases the poor prognostic significance of TP53 mutation in chronic lymphocytic leukemia
    Hua-Jie Dong
    Cheng Fang
    Li Wang
    Lei Fan
    Ji Xu
    Jia-Zhu Wu
    Ting-Xun Lu
    Jian-Yong Li
    Wei Xu
    Medical Oncology, 2014, 31
  • [27] TP53 Pro72 allele potentially increases the poor prognostic significance of TP53 mutation in chronic lymphocytic leukemia
    Dong, Hua-Jie
    Fang, Cheng
    Wang, Li
    Fan, Lei
    Xu, Ji
    Wu, Jia-Zhu
    Lu, Ting-Xun
    Li, Jian-Yong
    Xu, Wei
    MEDICAL ONCOLOGY, 2014, 31 (04)
  • [28] Racial disparities in patients with TP53 mutated acute myeloid leukemia.
    Badar, Talha
    Litzow, Mark Robert
    Shallis, Rory
    Stahl, Maximilian
    Bewersdorf, Jan Philipp
    Saliba, Antoine N.
    Correia, Guilherme Sacchi De Camargo
    Patel, Anand Ashwin
    Abaza, Yasmin
    Murthy, Guru Subramanian Guru
    Duvall, Adam
    Burkart, Madelyn
    Al-Kali, Aref
    Palmisiano, Neil
    Dinner, Shira
    Goldberg, Aaron David
    Atallah, Ehab L.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E19007 - E19007
  • [29] Clinical and prognostic values of TP53 mutation in patients with acute myeloid leukemia
    张莹
    ChinaMedicalAbstracts(InternalMedicine), 2020, 37 (01) : 59 - 59
  • [30] Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine
    Bories, Pierre
    Prade, Nais
    Lagarde, Stephanie
    Cabarrou, Bastien
    Largeaud, Laetitia
    Plenecassagnes, Julien
    Luquet, Isabelle
    De Mas, Veronique
    Filleron, Thomas
    Cassou, Manon
    Sarry, Audrey
    Fornecker, Luc-Matthieu
    Simand, Celestine
    Bertoli, Sarah
    Recher, Christian
    Delabesse, Eric
    PLOS ONE, 2020, 15 (10):